日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MR-Guided Radiotherapy in Oesophageal Cancer: From Principles to Practice-A Narrative Review

磁共振引导放射治疗在食管癌中的应用:从原理到实践——叙述性综述

Fong, Su Chen; Lau, Eddie; Liu, David S; Tebbutt, Niall C; Khor, Richard; Leong, Trevor; Williams, David; Uribe, Sergio; Ng, Sweet Ping

Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database

转移性结直肠癌不同治疗线患者特征及预后因素:来自 Aide et Recherche en Cancérologie Digestive 数据库的分析

Bachet, Jean-Baptiste; de Gramont, Aimery; Raeisi, Morteza; Rakez, Manel; Goldberg, Richard M; Tebbutt, Niall C; Van Cutsem, Eric; Haller, Daniel G; Hecht, J Randolph; Mayer, Robert J; Lichtman, Stuart M; Benson, Al B; Sobrero, Alberto F; Tabernero, Josep; Adams, Richard; Zalcberg, John R; Grothey, Axel; Yoshino, Takayuki; André, Thierry; Shi, Qian; Chibaudel, Benoist

Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines.

通过对 84 种人类 CRC 细胞系进行异种移植,揭示了高低级别结直肠癌 (CRC) 的模型系统和独特的生物学特征

Luk Ian Y, Mooi Jennifer K, Mouradov Dmitri, Tan Tao, Scott Cameron M, Chionh Fiona, Jenkins Laura J, Reehorst Camilla M, Nightingale Rebecca, Savas Peter, Tse Janson Wt, Crake Rebekah Li, Batlle Eduard, Arango Diego, Dopeso Higino, Gibbs Peter, Tebbutt Niall C, Luwor Rod B, Scott Andrew M, Basheer Faiza, Dhillon Amardeep S, Clemons Nicholas J, Williams David S, Firestein Ron, Sieber Oliver M, Mariadason John M

Fosl1 is a transcriptional effector of BRAF (V600E)-driven intestinal tumorigenesis

Fosl1是BRAF(V600E)驱动的肠道肿瘤发生的转录效应因子

Alam, Zakia; Nightingale, Rebecca; Lesmana, Analia; Liu, Cheng; Jenkins, Laura J; Richardson, Mark F; Croft, Lawrence; Luk, Ian Y; Reehorst, Camilla M; Chionh, Fiona; Vukelic, Natalia; Basheer, Faiza; Tulchinsky, Eugene; Badshah, Joshua; Dumenil, Troy; Bakiri, Latifa; Wagner, Erwin F; Tebbutt, Niall C; Whitehall, Vicki; Mariadason, John M; Dhillon, Amardeep S

Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer

匹配的原发性和转移性结直肠癌的分化程度高度一致

Reehorst, Camilla M; Mooi, Jennifer K; Uy, Charles J; Needham, Kristen A; Ellis, Sarah; Luk, Ian Y; Jenkins, Laura J; Nightingale, Rebecca; Chionh, Fiona; Behren, Andreas; Tebbutt, Niall C; Williams, David S; Mariadason, John M

Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment

胃食管癌腹膜液多组学评估(OMEGCA):一项前瞻性多中心队列研究方案,旨在检测接受根治性治疗患者的隐匿性腹膜转移

Liu, David S; Allan, Zexi; Tie, Jeanne; Hall, Katheryn; Lee, Margaret M; Wong, Darren J; Wong, Stephen Q; Tebbutt, Niall C; Watson, David I; Trochsler, Markus; Mori, Krinal; Winter, Nicole; Martin, Sarah; Ooi, Geraldine; Al-Habbal, Yahya; Ma, Ronald; Clemons, Nicholas J

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers

LIVER-R 研究方案:一项针对肝胆癌患者的基于度伐利尤单抗治疗方案的全球真实世界研究

Ikeda, Masafumi; Wörns, Marcus-Alexander; Akce, Mehmet; Hsu, Chiun; Tebbutt, Niall C; Casadei-Gardini, Andrea; Sah, Janvi; Farid-Kapadia, Mufiza; Stirnadel-Farrant, Heide A; Paskow, Michael J; Baur, Boris; Melillo, Giovanni; Schmidt, James; Daktera, Anna; Knox, Jennifer J

First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study

一线纳武利尤单抗和瑞拉利单抗联合化疗治疗胃或胃食管交界处腺癌:II期RELATIVITY-060研究

Hegewisch-Becker, Susanna; Mendez, Guillermo; Chao, Joseph; Nemecek, Radim; Feeney, Kynan; Van Cutsem, Eric; Al-Batran, Salah-Eddin; Mansoor, Wasat; Maisey, Nicholas; Pazo Cid, Roberto; Burge, Matthew; Perez-Callejo, David; Hipkin, R William; Mukherjee, Sourav; Lei, Ming; Tang, Hao; Suryawanshi, Satyendra; Kelly, Ronan J; Tebbutt, Niall C

A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study

一项针对BRAF V600E阳性转移性结直肠癌及其他癌症的BRAF和EGFR联合抑制剂Ib/II期临床试验:EVICT(厄洛替尼和维莫非尼联合用药试验)研究

Tan, Lavinia; Tran, Ben; Tie, Jeanne; Markman, Ben; Ananda, Sumi; Tebbutt, Niall C; Michael, Michael; Link, Emma; Wong, Stephen Q; Chandrashekar, Sushma; Guinto, Jerick; Ritchie, David; Koldej, Rachel; Solomon, Benjamin J; McArthur, Grant A; Hicks, Rodney J; Gibbs, Peter; Dawson, Sarah-Jane; Desai, Jayesh

SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer

SCORE:一项随机对照试验,旨在评估联合诊疗(全科医生和肿瘤科医生)随访与常规肿瘤科医生随访对结直肠癌幸存者的影响。

Jefford, Michael; Emery, Jon D; James Martin, Andrew; De Abreu Lourenco, Richard; Lisy, Karolina; Grunfeld, Eva; Mohamed, Mustafa Abdi; King, Dorothy; Tebbutt, Niall C; Lee, Margaret; Mehrnejad, Ashkan; Burgess, Adele; Marker, Julie; Eggins, Renee; Carrello, Joseph; Thomas, Hayley; Schofield, Penelope